Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INM-176 vs Donepezil in Alzheimer's Disease
NCT01245530Phase 3Completed
- Sponsor
- WhanIn Pharm
- Start
- Jun 2008
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of INM-176 in Alzheimer's disease (AD), sponsored by WhanIn Pharm. Started Jun 2008; status: completed.
02
Drugs
INM-176
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01245530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01245530.